Alzheimer’s: Monoclonal antibodies and vaccine candidates effective in mice
Alzheimer’s disease (AD) accounts for 60–70% of all dementia cases and is the sixth Trusted Source leading cause of death in adults in...
Family members frustrated as pandemic impacts Alzheimer's, dementia patients
Family members are speaking out about the effects of the pandemic’s social isolation on their loved ones with Alzheimer’s Disease and...
Human Study Suggests Brain Tissue Inflammation Is Key to Alzheimer’s Disease Progression
A University of Pittsburgh (Pitt) School of Medicine-led team has identified neuroinflammation as the key driver of the spread of...
Cognitive dysfunction linked to COVID-19
Scientists presenting research at the AAIC 2021, held online and in Denver, CO, have found links between COVID-19 and longer-term...
Advances in Alzheimer’s disease research
This month has seen some innovative advances with Alzheimer’s research, representing an important area of research as the global...
FDA Poised For Decision On Controversial Alzheimer's Drug
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease rather than...
The #1 Cause of Alzheimer's, According to Science
5.8 million Americans are currently suffering from Alzheimer's Disease, a progressive memory loss disease, per the Centers for Disease...
Alzheimer’s in the South: The Latest in Research
At the Alzheimer’s Association, we don’t know all of the answers. But we are intently working to understand how we achieve health equity...
Researchers discover new therapeutic target for Alzheimer's
Arizona [US], March 28 (ANI): By examining the role that cholesterol plays in both Alzheimer's disease and type 2 diabetes, researchers...
Language performance as a predictor of future Alzheimer’s disease
Language sample analysis may help predict future Alzheimer’s disease in people who are cognitively normal, suggesting that language...